# Pieter Hindryckx

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/pieter-hindryckx/

## Facts

| Field | Value |
| --- | --- |
| Citations | 5,828 |
| Field | Inflammatory Bowel Disease |
| h-index | 37 |
| i10-index | 71 |
| Last Known Institution | Ghent University Hospital |
| OpenAlex ID | https://openalex.org/A5045858994 |
| ORCID iD | 0000-0002-5949-2607 |
| Works | 193 |

## Researcher papers

- [Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders](https://scholariq.org/papers/third-european-evidence-based-consensus-on-diagnosis-and-management-of/)
- [Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial](https://scholariq.org/papers/ustekinumab-versus-adalimumab-for-induction-and-maintenance-therapy-in-biologic/)
- [Acute severe ulcerative colitis: from pathophysiology to clinical management](https://scholariq.org/papers/acute-severe-ulcerative-colitis-from-pathophysiology-to-clinical-management/)
- [Reduced Mucosa-associated <i>Butyricicoccus</i> Activity in Patients with Ulcerative Colitis Correlates with Aberrant Claudin-1 Expression](https://scholariq.org/papers/reduced-mucosa-associated-i-butyricicoccus-i-activity-in-patients-with/)
- [Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice](https://scholariq.org/papers/ursodeoxycholic-acid-and-its-taurine-or-glycine-conjugated-species-reduce/)
- [Treatment of Intestinal Fibrosis in Experimental Inflammatory Bowel Disease by the Pleiotropic Actions of a Local Rho Kinase Inhibitor](https://scholariq.org/papers/treatment-of-intestinal-fibrosis-in-experimental-inflammatory-bowel-disease-by/)
- [Intestinal hypoxia and hypoxia-induced signalling as therapeutic targets for IBD](https://scholariq.org/papers/intestinal-hypoxia-and-hypoxia-induced-signalling-as-therapeutic-targets-for-ibd/)
- [Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn’s Disease](https://scholariq.org/papers/vedolizumab-induces-endoscopic-and-histologic-remission-in-patients-with-crohn-s/)
- [Development and Validation of a Magnetic Resonance Index for Assessing Fistulas in Patients With Crohn’s Disease](https://scholariq.org/papers/development-and-validation-of-a-magnetic-resonance-index-for-assessing-fistulas/)
- [Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for Treatment of Pancreatic Insulinoma](https://scholariq.org/papers/endoscopic-ultrasound-guided-radiofrequency-ablation-versus-surgical-resection/)
- [Lumen‐apposing metal stents for anastomosis creation throughout the gastrointestinal tract: A large single‐center experience](https://scholariq.org/papers/lumen-apposing-metal-stents-for-anastomosis-creation-throughout-the/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Gallbladder and Bile Duct Disorders](https://scholariq.org/topics/gallbladder-and-bile-duct-disorders/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Esophageal and GI Pathology](https://scholariq.org/topics/esophageal-and-gi-pathology/)

## Researcher university

- [Ghent University Hospital](https://scholariq.org/institutions/ghent-university-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.